Apollo Hospitals and Tata Medical and Diagnostics (TataMD), a healthcare venture of the Tata group, on Thursday announced a partnership to introduce TataMD CHECK, the world's first CRISPR Cas-9 based diagnostic test, to help increase testing for Covid-19 across the country.

Apollo Hospitals, along with its subsidiary, Apollo Diagnostics will offer the testing in the National Capital Region (NCR) from the first week of December 2020.